Purge threatens state agency



Onderstepoort Biological Products (OBP), a state-owned animal vaccine manufacturer, faces allegations of capture after its board appointed a chief executive without him undergoing security vetting.

Baptiste Dungu had previously worked at OBP but had resigned in 2008 while being investigated for allegedly selling intellectual property and bacteria strains to private companies around the world.

Dungu’s appointment in March last year also did not follow the correct employment procedures; it did not have the approval of the Cabinet and company’s shareholder representative, the minister of agriculture.

The OBP produces bacterial, viral and blood vaccines for animals. These are sold to local and international markets. The company also holds strains of bacteria and viruses, some of which date back to the early 1920s.

Selling its vaccines brings in R160-million a year. But a plan to triple that income is being threatened by an alleged purge of senior staff members and the entire supply management team.

One of the OBP directors, Cynthia Nkuna, who was on the four-member panel that interviewed him, did not declare that she held directorships with him in two companies. A Companies and Intellectual Property Commission search shows that Nkuna and Dungu were appointed as directors of Saraf-Kgomo and Bacdunns on the same day in 2012, suggesting that they founded the companies together.

Nkuna could not be reached for comment this week. Text messages sent to her phone were not acknowledged.

As one of the country’s national key points, people need security clearance to work at the OBP.

Dungu’s last stint at the state-owned company came to an end when he resigned while under investigation for allegedly selling trade secrets and bacteria strains.

Althoughthe Mail &Guardian was able to establish this from sources with direct knowledge of the investigation and charges against Dungu, he and the OBP dismissed the allegations.

The company’s spokesperson, Lindiwe Mabena, said Dungu had left the OBP to pursue greener pastures. Dungu could not be reached on a cell number belonging to him.

Mabena said: “Dr Dungu was employed by OBP from 2002 to 2008 when he resigned to assume a position with GALVmed—Global Alliance for Livestock Veterinary Medicine. He was offered an executive position by an international company (positive career move).”

He added that the board had appointed a recruitment company, Kelly, in 2018 to find a new chief executive and Dungu had been one of three candidates who were interviewed. “The shortlisted candidates were subjected to vetting and clearance … The name was submitted to the former minister of agriculture, who signed and approved the appointment on 17th of December in 2018.”

She added: “The board is satisfied with the process followed to recruit the CEO [chief executive officer] for OBP.”

Department of Agriculture, Land Reform and Rural Development spokesperson Reggie Ngcobo said the department could not confirm whether Dungu’s appointment had received ministerial and Cabinet blessing. This is because the paperwork cannot be found as the previous minister, Senzeni Zokwana, and his team took all the documents in the minister’s office. This was disputed by a former senior staff member in Zokwana’s office, who said a two-day handover workshop was held when the former minister left.

“This reasoning also does not make sense because, although ministers sign appointment letters, the accounting officer is always the director general and he oversees the vetting, compiles Cabinet memos, and writes the appointment letters the minister signs. That letter should be there in the department’s records,” the former senior staff member added.

Insiders at the OBP claim that, since his arrival, Dungu has purged the company of the chief financial officer, Matsobane Gololo, the supply chain management team, the company secretary, Zodwa Mobeng, the head of the legal department, Ziphozami Linda, and the head of human resources, Mpume Ramutle.

Gololo and Ramute resigned in November, while Linda resigned in October. The OBP’s spokesperson Mabena was quoted in news reports saying all three senior employees resigned while on special leave or precautionary suspension pursuant to a forensic investigation instigated by the board.

The insiders said these staff changes were threatening a five-year upgrade of the OBP’s manufacturing facilities, which will cost nearly R1-billion. This upgrade would allow the state-owned entity to produce vaccines to the “good manufacturing practice” standard, potentially tripling its current R160-million revenue.

According to parliamentary committee meeting minutes from 2019, to date treasury has allocated the companyR492-million towards the upgrade. Without the upgrade, the OBP cannot sell to international markets and instead has to send its strains to other companies for beneficiation, cutting its chance of profiting from its work and intellectual property.

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever. But it comes at a cost. Advertisers are cancelling campaigns, and our live events have come to an abrupt halt. Our income has been slashed.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years. We’ve survived thanks to the support of our readers, we will need you to help us get through this.

To help us ensure another 35 future years of fiercely independent journalism, please subscribe.

Sabelo Skiti

Sabelo Skiti is an investigative journalist.


Zuma turns on judiciary as trial nears

Former president says pre-trial correspondence is part of another plot

High court declares Dudu Myeni delinquent

Disgraced former SAA chairperson Dudu Myeni has been declared a delinquent director by the...

SANDF inquiry clears soldiers of the death of Collins Khosa

The board of inquiry also found that it was Khosa and his brother-in-law Thabiso Muvhango who caused the altercation with the defence force members

Lockdown relief scheme payouts to employees tops R14-billion

Now employers and employees can apply to the Unemployment Insurance Fund for relief scheme payments

Press Releases

Obituary: Mohammed Tikly

His legacy will live on in the vision he shared for a brighter more socially just future, in which racism and discrimination are things of the past

Openview, now powered by two million homes

The future of free-to-air satellite TV is celebrating having two million viewers by giving away two homes worth R2-million

Road to recovery for the tourism sector: The South African perspective

The best-case scenario is that South Africa's tourism sector’s recovery will only begin in earnest towards the end of this year

What Africa can learn from Cuba in combating the Covid-19 pandemic

Africa should abandon the neoliberal path to be able to deal with Covid-19 and other health system challenges likely to emerge in future

Coexisting with Covid-19: Saving lives and the economy in India

A staggered exit from the lockdown accompanied by stepped-up testing to cover every district is necessary for India right now

Covid-19: Eased lockdown and rule of law Webinar

If you are arrested and fined in lockdown, you do get a criminal record if you pay the admission of guilt fine

Covid-19 and Frontline Workers

Who is caring for the healthcare workers? 'Working together is how we are going to get through this. It’s not just a marathon, it’s a relay'.

PPS webinar Part 2: Small business, big risk

The risks that businesses face and how they can be dealt with are something all business owners should be well acquainted with

The best local and international journalism

handpicked and in your inbox every weekday